These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 16921489
1. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Nie AY, McMillian M, Parker JB, Leone A, Bryant S, Yieh L, Bittner A, Nelson J, Carmen A, Wan J, Lord PG. Mol Carcinog; 2006 Dec; 45(12):914-33. PubMed ID: 16921489 [Abstract] [Full Text] [Related]
2. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat. Fielden MR, Adai A, Dunn RT, Olaharski A, Searfoss G, Sina J, Aubrecht J, Boitier E, Nioi P, Auerbach S, Jacobson-Kram D, Raghavan N, Yang Y, Kincaid A, Sherlock J, Chen SJ, Car B, Predictive Safety Testing Consortium, Carcinogenicity Working Group. Toxicol Sci; 2011 Nov; 124(1):54-74. PubMed ID: 21813463 [Abstract] [Full Text] [Related]
3. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Ellinger-Ziegelbauer H, Stuart B, Wahle B, Bomann W, Ahr HJ. Mutat Res; 2005 Aug 04; 575(1-2):61-84. PubMed ID: 15890375 [Abstract] [Full Text] [Related]
5. Analysis of gene expression in different stages of MeIQx-induced rat hepatocarcinogenesis. Kang JS, Wanibuchi H, Murai T, Morimura K, Kinoshita A, Fukushima S. Oncol Rep; 2007 Apr 04; 17(4):747-52. PubMed ID: 17342310 [Abstract] [Full Text] [Related]
8. Comparative analysis of predictive models for nongenotoxic hepatocarcinogenicity using both toxicogenomics and quantitative structure-activity relationships. Liu Z, Kelly R, Fang H, Ding D, Tong W. Chem Res Toxicol; 2011 Jul 18; 24(7):1062-70. PubMed ID: 21627106 [Abstract] [Full Text] [Related]
9. Acute hepatotoxicity: a predictive model based on focused illumina microarrays. Zidek N, Hellmann J, Kramer PJ, Hewitt PG. Toxicol Sci; 2007 Sep 18; 99(1):289-302. PubMed ID: 17522070 [Abstract] [Full Text] [Related]
10. Differences in gene expression profiles in the liver between carcinogenic and non-carcinogenic isomers of compounds given to rats in a 28-day repeat-dose toxicity study. Nakayama K, Kawano Y, Kawakami Y, Moriwaki N, Sekijima M, Otsuka M, Yakabe Y, Miyaura H, Saito K, Sumida K, Shirai T. Toxicol Appl Pharmacol; 2006 Dec 15; 217(3):299-307. PubMed ID: 17070881 [Abstract] [Full Text] [Related]
11. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Ellinger-Ziegelbauer H, Gmuender H, Bandenburg A, Ahr HJ. Mutat Res; 2008 Jan 01; 637(1-2):23-39. PubMed ID: 17689568 [Abstract] [Full Text] [Related]
12. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens. Rohrbeck A, Salinas G, Maaser K, Linge J, Salovaara S, Corvi R, Borlak J. Toxicol Sci; 2010 Nov 01; 118(1):31-41. PubMed ID: 20713471 [Abstract] [Full Text] [Related]
13. Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Elrick MM, Kramer JA, Alden CL, Blomme EA, Bunch RT, Cabonce MA, Curtiss SW, Kier LD, Kolaja KL, Rodi CP, Morris DL. Toxicol Pathol; 2005 Nov 01; 33(1):118-26. PubMed ID: 15805063 [Abstract] [Full Text] [Related]